ggressiveness of prostate cancer in certain patients and their ability to respond to treatment. Agus also served as Director of the Louis Warschaw Prostate Cancer Center, and as an attending physician in the Department of Medicine, Division of Medical Oncology at Cedars-Sinai. He was also an Associate Professor of M